PAFDX
Price
$35.95
Change
-$0.19 (-0.53%)
Updated
Jun 25 closing price
Net Assets
16.29B
RMFEX
Price
$58.19
Change
-$0.25 (-0.43%)
Updated
Jun 25 closing price
Net Assets
106.71B
Interact to see
Advertisement

PAFDX vs RMFEX

Header iconPAFDX vs RMFEX Comparison
Open Charts PAFDX vs RMFEXBanner chart's image
T. Rowe Price Equity Income Advisor
Price$35.95
Change-$0.19 (-0.53%)
VolumeN/A
Net Assets16.29B
American Funds American Mutual R4
Price$58.19
Change-$0.25 (-0.43%)
VolumeN/A
Net Assets106.71B
PAFDX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PAFDX vs. RMFEX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAFDX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 107B vs. PAFDX (16.3B). RMFEX (1.58) and PAFDX (1.56) have matching dividends . PAFDX was incepted earlier than RMFEX: PAFDX (25 years) vs RMFEX (23 years). PAFDX (0.98) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. PAFDX (21.40). RMFEX has a lower initial minimum investment than PAFDX: RMFEX (250) vs PAFDX (2500). RMFEX annual gain was more profitable for investors over the last year : 8.91 vs. PAFDX (1.47). RMFEX return over 5 years is better than : 65.19 vs. PAFDX (55.89).
PAFDXRMFEXPAFDX / RMFEX
Total Expense Ratio0.980.62158%
Annual Report Gross Expense Ratio0.980.62158%
Fund Existence25 years23 years-
Gain YTD5.0316.75774%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets16.3B107B15%
Annual Yield % from dividends1.561.5899%
Returns for 1 year1.478.9116%
Returns for 3 years14.8726.8055%
Returns for 5 years55.8965.1986%
Returns for 10 years26.5277.9934%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLS149.045.20
+3.62%
Celestica
ADNT19.35-0.06
-0.31%
Adient plc
IBIO0.73-0.02
-2.41%
iBio
NVCT7.74-0.24
-3.01%
Nuvectis Pharma
REPL9.45-0.30
-3.08%
Replimune Group